Dr Sophia Moldavsky, MD - Medicare Nephrology in Bryn Mawr, PA

Dr Sophia Moldavsky, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Bryn Mawr, Pennsylvania. She went to Temple University School Of Medicine and graduated in 1999 and has 25 years of diverse experience with area of expertise as Nephrology. She is a member of the group practice Bryn Mawr Medical Specialists Association and her current practice location is 830 Old Lancaster Rd Ste 206, Bryn Mawr, Pennsylvania. You can reach out to her office (for appointments etc.) via phone at (610) 525-8110.

Dr Sophia Moldavsky is licensed to practice in Pennsylvania (license number MD418591) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1043234438.

Contact Information

Dr Sophia Moldavsky, MD
830 Old Lancaster Rd Ste 206,
Bryn Mawr, PA 19010-3118
(610) 525-8110
Not Available



Physician's Profile

Full NameDr Sophia Moldavsky
GenderFemale
SpecialityNephrology
Experience25 Years
Location830 Old Lancaster Rd Ste 206, Bryn Mawr, Pennsylvania
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Sophia Moldavsky attended and graduated from Temple University School Of Medicine in 1999
  NPI Data:
  • NPI Number: 1043234438
  • Provider Enumeration Date: 07/27/2006
  • Last Update Date: 09/01/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 7113994856
  • Enrollment ID: I20040913001140

Medical Identifiers

Medical identifiers for Dr Sophia Moldavsky such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043234438NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology MD418591 (Pennsylvania)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Renal Care Group East, Inc.Bryn mawr, PADialysis facility
Bryn Mawr HospitalBryn mawr, PAHospital
Main Line Hospital LankenauWynnewood, PAHospital
Paoli HospitalPaoli, PAHospital
Riddle Memorial HospitalMedia, PAHospital
Hospital Of Univ Of PennsylvaniaPhiladelphia, PAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Bryn Mawr Medical Specialists Association418361093494

News Archive

First commercial procedure performed using Senza system for delivering Nevro's HF10 therapy

Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has been performed in the United States under the company's May 8th, 2015 FDA approval for commercial use of the Senza spinal cord stimulation (SCS) system, which delivers Nevro's proprietary HF10 therapy.

SARS-CoV-2 antibodies in breast milk: Study

A new study published on the medRxiv* preprint server explores the presence of immunoglobulin (Ig) antibodies IgA and IgG against SARS-CoV-2 in breast milk secreted by women with confirmed infection. The scientists also delineated the specific antigens targeted by the antibodies.

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

IQWiG finds no added benefit for ceritinib drug in adults with NSCLC

The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Sophia Moldavsky allows following entities to bill medicare on her behalf.
Entity NameBryn Mawr Medical Specialists Association
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1841226099
PECOS PAC ID: 4183610934
Enrollment ID: O20040426000467

News Archive

First commercial procedure performed using Senza system for delivering Nevro's HF10 therapy

Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has been performed in the United States under the company's May 8th, 2015 FDA approval for commercial use of the Senza spinal cord stimulation (SCS) system, which delivers Nevro's proprietary HF10 therapy.

SARS-CoV-2 antibodies in breast milk: Study

A new study published on the medRxiv* preprint server explores the presence of immunoglobulin (Ig) antibodies IgA and IgG against SARS-CoV-2 in breast milk secreted by women with confirmed infection. The scientists also delineated the specific antigens targeted by the antibodies.

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

IQWiG finds no added benefit for ceritinib drug in adults with NSCLC

The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.

Read more Medical News

› Verified 5 days ago

Entity NameBryn Mawr Nephrology Assoc Ltd
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093826547
PECOS PAC ID: 6709865751
Enrollment ID: O20040714001338

News Archive

First commercial procedure performed using Senza system for delivering Nevro's HF10 therapy

Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has been performed in the United States under the company's May 8th, 2015 FDA approval for commercial use of the Senza spinal cord stimulation (SCS) system, which delivers Nevro's proprietary HF10 therapy.

SARS-CoV-2 antibodies in breast milk: Study

A new study published on the medRxiv* preprint server explores the presence of immunoglobulin (Ig) antibodies IgA and IgG against SARS-CoV-2 in breast milk secreted by women with confirmed infection. The scientists also delineated the specific antigens targeted by the antibodies.

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

IQWiG finds no added benefit for ceritinib drug in adults with NSCLC

The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Sophia Moldavsky is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Sophia Moldavsky, MD
830 Old Lancaster Rd Ste 206,
Bryn Mawr, PA 19010-3118

Ph: (610) 525-8110
Dr Sophia Moldavsky, MD
830 Old Lancaster Rd Ste 206,
Bryn Mawr, PA 19010-3118

Ph: (610) 525-8110

News Archive

First commercial procedure performed using Senza system for delivering Nevro's HF10 therapy

Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has been performed in the United States under the company's May 8th, 2015 FDA approval for commercial use of the Senza spinal cord stimulation (SCS) system, which delivers Nevro's proprietary HF10 therapy.

SARS-CoV-2 antibodies in breast milk: Study

A new study published on the medRxiv* preprint server explores the presence of immunoglobulin (Ig) antibodies IgA and IgG against SARS-CoV-2 in breast milk secreted by women with confirmed infection. The scientists also delineated the specific antigens targeted by the antibodies.

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

IQWiG finds no added benefit for ceritinib drug in adults with NSCLC

The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.

Read more News

› Verified 5 days ago


Internal Medicine Doctors in Bryn Mawr, PA

Dr. Sameer Gupta, MD, MPH
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010
Phone: 610-527-3800    Fax: 610-527-0334
Kellie Ann Matson, PA-C
Nephrology
Medicare: Medicare Enrolled
Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010
Phone: 484-337-3000    
John Steers, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010
Phone: 610-527-1165    Fax: 610-527-6611
Dr. Clarke U. Piatt, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010
Phone: 610-527-3800    Fax: 610-527-0334
Francis P. Day, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010
Phone: 610-527-3800    Fax: 610-527-0334
Robert R Atkins, M.D.
Nephrology
Medicare: Medicare Enrolled
Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010
Phone: 610-527-3800    Fax: 610-527-0334

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.